Lilly’s second immune-oncology candidate using Zymeworks’ Azymetric platform to start clinical trials

Zymeworks, a clinical-stage biopharmaceutical company developing multifunctional therapeutics, reported the achievement of a new development milestone in its collaboration with Eli Lilly and Company (“Lilly”).